Pepsin
Explore a selection of our essential drug information below, or:
Identification
- Summary
Pepsin is a protease indicated in the treatment of digestive disorders.
- Generic Name
- Pepsin
- DrugBank Accession Number
- DB13198
- Background
Pepsin is a potent enzyme in gastric juice that digests proteins such as those in meat, eggs, seeds, and dairy products 12.
Studies on gastric digestion from 1820-1840 led to the discovery of pepsin as the substance which, in the presence of stomach acid, causes nutrients including meat or coagulated egg whites to dissolve. Soon afterward, it was shown that these protein nutrients were cleaved by pepsin to products called peptones 2.
Pepsin is often used as a replacement enzyme for those with pancreatic insufficiency 11. Stimulation of the pancreas and therefore enzymatic digestion of food is a tightly controlled and is a hormonally mediated process. Any changes or conditions affecting metabolic steps for successful digestion and absorption negatively affect pancreatic enzymatic secretion, entry into the intestine, functionality once inside the intestine, and appropriate mixing with foods/nutrients. Many causes of pancreatic insufficiency require that enzyme replacement therapy is started, including cystic fibrosis, pancreatic cancer, acute and chronic pancreatitis, as well as pancreatic surgery 11.
Pepsin is approved by the FDA and is used in food at levels not to exceed current good manufacturing practice 17. Interestingly, it has been used as a marker for laryngopharyngeal reflux (LPR), which is a common illness of otolaryngology (ear, nose and throat specialist) visits 3.
Interestingly, recent research has suggested that pepsin participates in the digestion of nucleic acids 22.
- Type
- Biotech
- Groups
- Approved, Experimental, Investigational
- Biologic Classification
- Protein Based Therapies
Other protein based therapies - Protein Chemical Formula
- Not Available
- Protein Average Weight
- Not Available
- Sequences
> Pepsin A Sus Scrofa (Pig) MKWLLLLSLVVLSECLVKVPLVRKKSLRQNLIKNGKLKDFLKTHKHNPASKYFPEAAALI GDEPLENYLDTEYFGTIGIGTPAQDFTVIFDTGSSNLWVPSVYCSSLACSDHNQFNPDDS STFEATSQELSITYGTGSMTGILGYDTVQVGGISDTNQIFGLSETEPGSFLYYAPFDGIL GLAYPSISASGATPVFDNLWDQGLVSQDLFSVYLSSNDDSGSVVLLGGIDSSYYTGSLNW VPVSVEGYWQITLDSITMDGETIACSGGCQAIVDTGTSLLTGPTSAIANIQSDIGASENS DGEMVISCSSIDSLPDIVFTINGVQYPLSPSAYILQDDDSCTSGFEGMDVPTSSGELWIL GDVFIRQYYTVFDRANNKVGLAPVA
Download FASTA Format- Synonyms
- Lactated pepsin
- Pepsin A
- Pepsin porcine
- Pepsin, bovine
- Pepsina
- Saccharated pepsin
Pharmacology
- Indication
Used as a pancreatic enzyme replacement in pancreatic insufficiency 11. It is intended to mimic naturally produced human pepsin 14.
Pepsin powder is prepared from the gastric mucosa of pigs, cattle or sheep 19. In the laboratory, it is primarily used for the unspecific hydrolysis of proteins and peptides in acidic media. In addition, it provides limited hydrolysis of native immunoglobulins, yielding biologically active fragments 7.
In certain supplements, pepsin may be combined with betaine and HCl (hydrochloric acid) to aid in digestion in various gastrointestinal conditions 14, 6.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination to treat Diarrhea Combination Product in combination with: Glutamic acid (DB00142) •••••••••••• ••••••• •••• •••••• Used in combination to treat Gastritis chronic Combination Product in combination with: Glutamic acid (DB00142) •••••••••••• ••••••• •••• •••••• Used in combination to treat Hypochlorhydria Combination Product in combination with: Glutamic acid (DB00142) •••••••••••• ••••••• •••• •••••• Used in combination to treat Postoperative digestive insufficiency Combination Product in combination with: Glutamic acid (DB00142) •••••••••••• ••••••• •••• •••••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Pepsin digests protein 12. It classified by the FDA that is characterizing enzyme activity is that of a peptide hydrolase 17.
- Mechanism of action
Glands present in the mucous membrane lining of the stomach produce and store an inactive protein named pepsinogen. Impulses from the vagus nerve and the hormonal secretions of the hormones gastrin and secretin promote the release of pepsinogen into the stomach, where it is mixed with hydrochloric acid and quickly converted to the active enzyme pepsin. The digestive potency of pepsin is highest at the acidic pH of normal gastric juice. In the intestine, the gastric acids are then neutralized, and pepsin is no longer effective 12.
Pepsin, the proteolytic enzyme of the stomach is normally responsible for less than 20% of the protein digestion occuring the gastrointestinal tract. It is an endopeptidase enzyme that metabolizes proteins to peptides. It preferentially hydrolyzes peptide linkages where one of the amino acids is aromatic. Pepsin, like other protease enzymes, is produced from an inactive precursor, pepsinogen, which is stored in granule form in the chief cells of the stomach and are released by a process called exocytosis 16.
In the digestive tract, pepsin activity only contributes to the partial breakdown of proteins into smaller units called peptides, which then either are absorbed from the intestine into the bloodstream or are broken down further by pancreatic enzymes 12.
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
Pepsin is the first of several enzymes that digest proteins. In the stomach, polypeptide chains bind in the deep active site groove of pepsin, and are then digested into smaller pieces. Following this, a variety of proteases and peptidases in the intestine complete the process. The small fragments, which are amino acids and dipeptides, are then absorbed by cells for use as metabolic energy or construction of new proteins 15.
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Oral LD50 Rat 90000 mg/kg MSDS
Chronic backflow of pepsin, acid, and other substances from the stomach into the esophagus, is the basis of reflux conditions, particularly gastroesophageal reflux disease (GERD) and laryngopharyngeal reflux. In the latter, pepsin and acid travel all the way up to the larynx, where they can lead to damage of the laryngeal mucosa and lead to symptoms ranging from hoarseness of the voice and chronic cough to laryngospasm (involuntary contraction of the vocal cords) as well as laryngeal cancer 12.
Though limited data is available on the toxicity of exogenous pepsin (not naturally produced in one's gastrointestinal tract), it can be extrapolated from the above-mentioned information that pepsin overdose may lead to mucosal tissue damage of the gastrointestinal tract.
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Drink plenty of fluids.
- Take before a meal.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Digestex Liquid 100 mg / 30 mL Oral Theralab Inc. 1981-04-25 2000-08-01 Canada - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Bemosin Tab Pepsin (130 mg) + Ammonium chloride (97.2 mg) + Betaine hydrochloride (130 mg) Tablet Oral Therapeutic Foods Co. 1988-12-31 2003-07-16 Canada Betaine HCl and Pepsin Pepsin (135 mg) + Betaine hydrochloride (324 mg) Tablet Oral Rheingold Food International Ltd. 1985-12-31 2007-07-26 Canada Betasin Tab Pepsin (130 mg / tab) + Ammonium chloride (97.2 mg / tab) + Betaine hydrochloride (130 mg / tab) Tablet Oral Bio Vita 1987-12-31 1996-09-09 Canada Debiline Pepsin (50 mg) + Deoxycholic acid (100 mg) Tablet Oral Lab Nadeau LtÉe, Division Of Technilab Inc. 1951-12-31 1999-09-28 Canada Debiline H Pepsin (50 mg / tab) + Deoxycholic acid (100 mg / tab) + Homatropine methylbromide (2.5 mg / tab) Tablet Oral Lab Nadeau LtÉe, Division Of Technilab Inc. 1951-12-31 1999-09-28 Canada
Categories
- ATC Codes
- A09AC01 — Pepsin and acid preparations
- A09AC — Enzyme and acid preparations, combinations
- A09A — DIGESTIVES, INCL. ENZYMES
- A09 — DIGESTIVES, INCL. ENZYMES
- A — ALIMENTARY TRACT AND METABOLISM
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- Not Available
- Kingdom
- Organic Compounds
- Super Class
- Organic Acids
- Class
- Carboxylic Acids and Derivatives
- Sub Class
- Amino Acids, Peptides, and Analogues
- Direct Parent
- Peptides
- Alternative Parents
- Not Available
- Substituents
- Not Available
- Molecular Framework
- Not Available
- External Descriptors
- Not Available
- Affected organisms
- Humans and other mammals
Chemical Identifiers
- UNII
- GID333S43J
- CAS number
- 9001-75-6
References
- General References
- Iannella G, Di Nardo G, Plateroti R, Rossi P, Plateroti AM, Mariani P, Magliulo G: Investigation of pepsin in tears of children with laryngopharyngeal reflux disease. Int J Pediatr Otorhinolaryngol. 2015 Dec;79(12):2312-5. doi: 10.1016/j.ijporl.2015.10.034. Epub 2015 Oct 30. [Article]
- Fruton JS: A history of pepsin and related enzymes. Q Rev Biol. 2002 Jun;77(2):127-47. [Article]
- Calvo-Henriquez C, Ruano-Ravina A, Vaamonde P, Martinez-Capoccioni G, Martin-Martin C: Is Pepsin a Reliable Marker of Laryngopharyngeal Reflux? A Systematic Review. Otolaryngol Head Neck Surg. 2017 Sep;157(3):385-391. doi: 10.1177/0194599817709430. Epub 2017 Jun 6. [Article]
- Petersen KU: Pepsin and Its Importance for Functional Dyspepsia: Relic, Regulator or Remedy? Dig Dis. 2018;36(2):98-105. doi: 10.1159/000481399. Epub 2017 Oct 5. [Article]
- Hedemann MS, Jensen BB: Variations in enzyme activity in stomach and pancreatic tissue and digesta in piglets around weaning. Arch Anim Nutr. 2004 Feb;58(1):47-59. [Article]
- Nutritional Interventions for Gastroesophageal Reflux, Irritable Bowel Syndrome, and Hypochlorhydria: A Case Report [Link]
- Pepsin, Sigma Aaldrich [Link]
- Effect of Pepsin on the Absorption of Food Vitamin B12 and Iron [Link]
- Pepsin [Link]
- Pepsin: science.gov topics [Link]
- Pancreatic Enzyme Replacement Therapy During Pancreatic Insufficiency [Link]
- Pepsin [Link]
- Gastritis [Link]
- Zypan [Link]
- PDB-pepsin [Link]
- NIH Dictionary- Pepsin [Link]
- Code of Federal Regulations, Pepsin [Link]
- Pepsin Drug Monograph [Link]
- Pepsin, Drugs.com [Link]
- Determining the Safety of Enzymes Used in Food Processing [Link]
- PEPSIN, SIGMA AALDRICH [Link]
- Digestion of Nucleic Acids Starts in the Stomach [Link]
- External Links
- MSDS
- Download (282 KB)
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample dataNot Available Completed Not Available Abdominal Pain / Dyspepsia / Flatulence / Functional Gastrointestinal Disorders (FGID) / Nausea / Vomiting 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Liquid Oral 100 mg / 30 mL Tablet, delayed release Oral Tablet Oral Tablet, film coated Oral Tablet - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source water solubility very soluble MSDS
Drug created at June 23, 2017 20:37 / Updated at June 05, 2021 09:12